Eshelman Ventures is a venture capital firm focused on investment in private healthcare companies.
Eshelman Ventures has made investments in Sapience Therapeutics, Aruna Biomedical, G1 Therapeutics, Cellective BioTherapy, Innocrin Pharmaceuticals and Dignify Therapeutics.
Eshelman Ventures has exited investments in G1 Therapeutics.
Eshelman Ventures has made investments in Sapience Therapeutics, Aruna Biomedical, G1 Therapeutics, Cellective BioTherapy, Innocrin PharmaceuticalsInnocrin Pharmaceuticals and Dignify Therapeutics.
Eshelman Ventures has made investments in Sapience Therapeutics, Aruna BiomedicalAruna Biomedical, G1 Therapeutics, Cellective BioTherapy, Innocrin Pharmaceuticals and Dignify Therapeutics.
Eshelman Ventures has made investments in Sapience TherapeuticsSapience Therapeutics, Aruna Biomedical, G1 Therapeutics, Cellective BioTherapy, Innocrin Pharmaceuticals and Dignify Therapeutics.
Eshelman Ventures is a Wilmington, North CarolinaWilmington, North Carolina based venture capital firm. They focus their investment in private healthcare companies.
Eshelman Ventures is a venture capital firm focused on investment in private healthcare companies.
Eshelman Ventures is a Wilmington, North Carolina based venture capital firm. They focus their investment in private healthcare companies.
Eshelman Ventures has made investments in Sapience Therapeutics, Aruna Biomedical, G1 Therapeutics, Cellective BioTherapy, Innocrin Pharmaceuticals and Dignify Therapeutics.
Eshelman Ventures has exited investments in G1 Therapeutics.